- Syndax Pharmaceuticals (SNDX) is scheduled to announce Q3 earnings results on Monday, November 3rd, after market close. The consensus EPS Estimate is -$0.71 (+27.6% Y/Y) and the consensus Revenue Estimate is $47.97M (+283.8% Y/Y).Over the last 3 months, EPS estimates have seen 10
Syndax Pharmaceuticals Q3 2025 Earnings Preview
17 hours ago
1
Related
Uber Q3 earnings preview: Gross bookings and AV partnerships...
9 minutes ago
0
U.S. PMI Manufacturing unexpectedly edges up in October
9 minutes ago
0
Airbus October deliveries are said to rise amid year-end pro...
12 minutes ago
0
SA Charts: China EV Market - NIO and XPeng extend growth mom...
14 minutes ago
0
KeyBanc cuts rating on Charter after Q3 results stoke fears ...
14 minutes ago
0
Ovintiv Q3 2025 Earnings Preview
15 minutes ago
0
Steel Dynamics added as a new short at Hedgeye
15 minutes ago
0
ISM Manufacturing unexpectedly drops in October
17 minutes ago
0
Simon acquires Taubman Realty in full
17 minutes ago
0
Clean Energy Fuels Q3 2025 Earnings Preview
18 minutes ago
0
Here are the major earnings after the close Monday
19 minutes ago
0
Bitcoin Strategy ETF declares monthly distribution of $0.838...
19 minutes ago
0
Schwab 5-10 Year Corporate Bond ETF declares $0.1018 dividen...
20 minutes ago
0
This ETF is handily beating the S&P 500—and analysts say it ...
20 minutes ago
0
BP Q3 earnings expected at $0.77 EPS on $43.6B revenue; upst...
20 minutes ago
0
ProShares High Yield—Interest Rate Hedged declares monthly d...
20 minutes ago
0
Schwab U.S. TIPS ETF declares $0.0917 dividend
21 minutes ago
0
Schwab Intermediate-Term U.S. Treasury ETF declares $0.0864 ...
24 minutes ago
0
Harmony Biosciences Holdings, Inc. Q3 2025 Earnings Preview
25 minutes ago
0
The Consumer Discretionary Select Sector SPDR Premium Income...
26 minutes ago
0
Popular
English (US) · © FBT Company 2025. All rights are reserved